• TGFB3 Gene Mutation Analysis
  • Norovirus, EIA, Stool
  • Double Stranded DNA Antibody
  • B and T Cell Gene Rearrangement, Blood
  • Mumps Virus Antibody, IgG, IgM
  • Cutaneous Immunofluorescence Antibodies, IgG
  • 5-hydroxytryptamine receptor 1A (HTR1A)
  • Treponema pallidum Antibody by TP-PA, Serum
  • Amphetamine, Urine
  • UDP-glucuronosyl Transferase 1A6 (UGT1A6) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Methodology
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.